High Growth Rates and Insider Buying - Yet the Stock Falls?
Long-term megatrends such as the aging population and the increase in chronic diseases are likely to positively influence Insulet's growth!
The insider purchase by CEO McEvoy in the amount of over one million dollars is a strong vote of confidence!
Reading Time: 1 minute
Insulet Corp. (PODD) specializes in providing solutions for people with diabetes and aims to fundamentally improve the lives of patients through continuous and automated insulin delivery. Instead of relying on traditional pumps with cumbersome tubes, Insulet offers a compact, portable system that is discreetly worn on the body. The flagship products like the Omnipod 5 system and the associated data management platform Omnipod Discover form the strong backbone of the company’s strategy. The aging population and the increasing prevalence of chronic...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
